Zydus Lifesciences Limited has informed the Exchange regarding a press release dated September 04, 2025, titled "Zydus and Synthon entered into exclusive licensing and supply agreement for Ozanimod Capsules (generic version of ZEPOSIA®) for the U.S. market".